Repeated Injection of GnRH Agonist to Reduce Ovarian Hyperstimulation Syndrome

NAUnknownINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

June 30, 2016

Conditions
Infertility and at High Risk of OHSS
Interventions
DRUG

triptorelin

0.2 mg, ih, at night and 0.2 mg, ih, 12 hours later when at least one of the following criteria was reached: (i) serum E2 ≥3500 pg/ml, (ii) ≥18 follicles measuring ≥11 mm.

Trial Locations (1)

510515

RECRUITING

Center for Reproductive Medicine, Department of Gynecology and Obstetrics, Nanfang Hospital, Southern Medical University, Guangzhou

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Natural Science Foundation of China

OTHER_GOV

collaborator

Comprehensive Strategic Cooperation Project of Guangdong Province and Chinese Academy of Science

OTHER

collaborator

Guangzhou Science and Technology Program key projects

OTHER

collaborator

National Key Basic Research Development Plan of China

UNKNOWN

lead

Chenshiling

OTHER